OOIR: Observatory of International Research

Papers

(The TQCC of Pituitary is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey	186
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	64
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	59
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	46
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	42
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	40
Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022	40
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	36
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	35
Increased impulsivity and higher odds of compulsive shopping among cabergoline-treated patients with prolactinoma: a case-control study	27
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life	25
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	22
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	22
Pituitary: hic manebimus optime	21
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	21
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery	20
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	19
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	19
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	19
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	18
Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates	18
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study	18
Non-written guidelines in pituitary tumor surgery. The hidden curriculum	17
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria	16
Pituitary metastases: a case series and scoping review	16

Genetic models of Cushing’s disease	16
Authors‘ reply to the letter to the editor by Fedai et al.: “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”	15
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	15
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	15
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	15
Consensus on acromegaly complications: an update	15
Diagnosis of growth hormone deficiency: searching for Consensus along life	15
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	15
Delayed diagnosis of ectopic ACTH-secreting tumors following transsphenoidal surgery for presumed MRI-negative Cushing’s disease: implications for long-term surveillance	15
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	15
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	14
IGF-1 is positively associated with BMI in patients with acromegaly	14
Diagnostic performance of desmopressin stimulation test in pediatric cushing’s disease	14
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	14
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	14
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	14
TSH-secreting pituitary adenomas and bone	14
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	14
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	14
GH Stimulation testing is unnecessary in patients with hypothalamic–pituitary disease, preserved pituitary function, and IGF-I SDS ≥ 0	13
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	13
Cushing’s disease and bone	13
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	13
Development and validation of clinical screening systems for Cushing disease in the United States	12
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	12
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	12
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	12
Circadian rhythm proteins as potential biomarkers in pituitary adenomas: an immunohistochemical analysis	11
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	11
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study	11
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition	11
The impact of growth hormone (GH) on immunosenescence: exploring the role of B and T cells	11
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	10
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	10
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	10
Determinants of remission and recurrence following transsphenoidal surgery for prolactinoma: a single-center experience	10
Pituitary surgery and COVID	10
Is diabetes with acromegaly for life?	10
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly	10
Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort	10
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	10
Copeptin after pituitary surgery: is it worth measuring?	10
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	10
Long COVID and pituitary dysfunctions: a bidirectional relationship?	10
Gauze swabbing technique for safe dissection of pituitary tumors	9
Validation and modification of the PANOMEN 3 classification for predicting long-term recurrence/progression and quality of life in patients with pituitary adenomas: a multicentre retrospective cohort	9
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?	9
Nelson’s syndrome: reappraisal of an uncommon disease	9
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study	9
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort	9

Impulse control disorders and their relationship with psychopathology in patients treated with cabergoline for hyperprolactinaemia	9
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	9
Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly	9
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	8
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	8
Higher surgical cure of pediatric gigantism with endoscopic endonasal surgery: case series and review of the literature	8
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	8
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	8
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	8
Refractory nonfunctioning pituitary adenomas	8
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	8
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease	8
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	8
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	8
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis	8
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	8
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	7
Skeletal fragility in pituitary disease: how can we predict fracture risk?	7
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	7
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	7
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	7
Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study	7
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database	7
Pituitary stalk biopsy – A systematic review of the safety and efficacy of stalk lesion biopsy	7
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	7
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	7
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	7
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	7
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	7
Recent progress in the understanding of psychological complications of acromegaly: toward a longitudinal clinical phenotype	7
How to manage intolerance to dopamine agonist in patients with prolactinoma	7
An update on, and genetics of refractory adenomas of childhood	7
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	7
A Retrospective cohort study of Knosp grade reporting of cavernous sinus invasion in pituitary macroadenomas	7
Etomidate in severe hypercortisolism: early cortisol kinetics and clinical outcomes in a real-world cohort	7
Giant prolactinomas, a detailed analysis of 196 adult cases	7
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis	7
Correction: consensus on criteria for acromegaly diagnosis and remission	7
Cushing’s syndrome: Guidance on thromboprophylaxis at last	7
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	6
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	6
Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications	6
Postoperative weight gain following endoscopic endonasal surgery for craniopharyngiomas in children and adults: A retrospective cohort study	6
Sex differences in the clinical presentation, management and long-term outcomes of pituitary tumors in children and adolescents	6
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	6
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	6
Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism	6
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	6
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	6
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	6
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	6
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	6
Old and new pituitary biomarkers: evidence for sex-specificity	6
Persistent barriers to growth hormone replacement therapy for adults	6
Critical views for safe surgical phase progression in endoscopic endonasal transsphenoidal pituitary adenoma resection: modified Delphi consensus	6
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	6
Prolactinoma-associated headache: Clinical and radiological correlates and long-term outcomes	6
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	6